According to the latest report by Reports and Data, the Neutral Human Milk Oligosaccharides market size was USD 143.16 Million in 2022 and is expected to reach USD 484.25 Million in 2032, and register a revenue CAGR of 14.5% during the forecast period. The growth of the HMO market is attributed to its functional benefits in infant formula and various other nutritional food items, as well as food supplements. To meet the demand for HMO, major companies are investing in new production methods, such as separating HMO from cow milk or using microorganisms, which is cost-effective due to the availability of low-cost substrates.

However, the HMO market is hindered by the lack of large-scale manufacturing methods, high research and development costs, and strict federal regulations. The primary application for HMO is baby food, which improves newborns’ health and aids in disease prevention. Additionally, HMOs play a crucial role in brain development. Producers such as Inbiose NV and Abbott use fermentation technologies, chemical and enzymatic synthesis, and other techniques to produce human milk oligosaccharides, which drive market revenue growth. Nonetheless, chemical and enzymatic synthesis processes are expensive and have low raw material availability in the market, hampering market revenue growth.

To Get a Sample Copy of the Report, Click On @ https://www.reportsanddata.com/download-free-sample/1303

Major Companies:

• BioGaia AB
• DuPont de Nemours, Inc.
• Inbiose NV
• Nestlé S.A.
• FrieslandCampina Domo
• ZuChem Inc.
• Prolacta Bioscience
• Abbott Laboratories
• Jennewein Biotechnologie GmbH
• HMO Bioengineering
• Evonik Industries AG

Driving Factors and Restrain of Neutral Human Milk Oligosaccharides Market:

The Neutral Human Milk Oligosaccharides market is expected to grow significantly in the coming years, driven by several factors. The functional benefits of HMO in infant formula and various other nutritional food items as well as food supplements are one of the primary drivers of market growth. The extensive availability of low-cost substrates is another factor contributing to the growth of the HMO market, as simple sugars can be converted into HMOs by microbial cell factories, making the production process cost-effective. Additionally, major companies in the HMO market are investing in new methods of production to meet the growing demand for HMO.

However, there are also several factors restraining the growth of the HMO market. The lack of large-scale manufacturing methods is a significant challenge, as it limits the ability to produce HMO on a larger scale. High research and development costs are another factor hampering the growth of the HMO market, as it is a relatively new field and requires significant investment in research and development. Additionally, strict federal regulations and low raw material availability in the market for chemical and enzymatic synthesis processes are also hindering the growth of the HMO market. Despite these challenges, the growing demand for HMO and the investments being made by major companies in the field suggest that the HMO market will continue to grow in the coming years.

To know more about the report @ https://www.reportsanddata.com/report-detail/human-milk-oligosaccharides-hmo-market

Segmentation:

Product Outlook (Revenue, USD Billion; 2019-2030)

• Fucosyllactose
• Sialyllactose
• Lacto-N-Tetraose
• Lacto-N-Neotetraose

Application Outlook (Revenue, USD Billion; 2019-2030)

• Functional Food & Beverages
• Infant Formula
• Food Supplements
• Others

Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)

• Hypermarkets & Supermarkets
• Drug Store or Pharmacy
• Mass Merchandiser
• Departmental Stores
• Mono-Brand Stores
• Specialty Stores
• Online Sales Channels

Regional Outlook (Revenue, USD Billion; 2019-2030)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Sweden
  • BENELUX
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Rest of MEA

Get Explore Latest Research Report by Reports and Data:

http://www.google.bg/url?sa=t&url=https://www.reportsanddata.com/

http://www.google.at/url?sa=t&url=https://www.reportsanddata.com/

http://www.google.ae/url?sa=t&url=https://www.reportsanddata.com/

http://maps.google.ws/url?q=https://www.reportsanddata.com/

http://maps.google.vu/url?q=https://www.reportsanddata.com/

http://maps.google.vg/url?q=https://www.reportsanddata.com/

http://maps.google.tt/url?q=https://www.reportsanddata.com/

http://maps.google.to/url?q=https://www.reportsanddata.com/

http://maps.google.tn/url?q=https://www.reportsanddata.com/

http://maps.google.tl/url?q=https://www.reportsanddata.com/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com